Company LabGenomics Co., Ltd.

Equities

A084650

KR7084650001

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for LabGenomics Co., Ltd.

Quarterly revenue - Rate of surprise

Sector Medical & Diagnostic Laboratories

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
2,740 ^KRW	0.00%		+2.24%	-28.92%

2023	LabGenomics USA LLC announced that it has received KRW 75.948 billion in funding from LabGenomics Co., Ltd.	CI
2023	LabGenomics USA LLC announced that it expects to receive KRW 70 billion in funding from LabGenomics Co., Ltd.	CI

LabGenomics Co., Ltd is a Korea-based company engaged in the provision of in vitro diagnostic (IVD) services. The Company mainly provides IVD services, including general diagnostic check services, molecular diagnostic check services, and research and development services. The Companyâs IVD products include deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) kits and others. It also provides examination for breast cancer and colorectal cancer, biosensor for point of care testing (POCT) and others. It also provides healthy food.

KRW in Million	2022	Weight	2023	Weight	Delta
Molecular Diagnostic Test Service 57.6 %	88,880	61.4 %	42,123	57.6 %	-52.61%
General Inspection Service 26.0 %	18,351	12.7 %	18,981	26.0 %	+3.43%
Research Service 9.4 %	7,709	5.3 %	6,902	9.4 %	-10.47%
Product 6.6 %	29,577	20.4 %	4,818	6.6 %	-83.71%
Return on Investment 0.4 %	200	0.1 %	291	0.4 %	+45.96%
Other 0.0 %	57	0.0 %	11	0.0 %	-79.84%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 68.9 %	129,301	89.3 %	50,391	68.9 %	-61.03%
United States 29.5 %	2,773	1.9 %	21,575	29.5 %	+677.91%
Asia 0.9 %	11,830	8.2 %	661	0.9 %	-94.41%
Europe 0.7 %	777	0.5 %	499	0.7 %	-35.77%

Managers	Title	Age	Since
Seung-Hyun Jin CEO	Chief Executive Officer	56	02-03-28
Myung-Shin Kim CTO	Chief Tech/Sci/R&D Officer	56	19-03-31
Yong-Sik Won COO	Chief Operating Officer	51	09-12-31
Taek-Seong Song AUD	Comptroller/Controller/Auditor	60	21-03-28

Members of the board	Title	Age	Since
Seung-Hyun Jin CEO	Chief Executive Officer	56	02-03-28
Sung-Yong Ahn BRD	Director/Board Member	55	17-03-27
Won-Hui Hwang BRD	Director/Board Member	58	22-03-30
Yong-Sik Won COO	Chief Operating Officer	51	09-12-31
Myung-Shin Kim CTO	Chief Tech/Sci/R&D Officer	56	19-03-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	74,239,990	61,802,718 ( 83.25 %)	0	83.25 %

Name	Equities	%	Valuation
Luha Private Equity, Inc. 16.16 %	11,999,534	16.16 %	27 M ₩
MACROGEN, INC. 1.799 %	1,335,288	1.799 %	3 M ₩
Sun-kil Kwon 0.0398 %	29,553	0.0398 %	66 625 ₩
Gwang-jin Seong 0.0380 %	28,208	0.0380 %	63 592 ₩
Dimensional Fund Advisors Ltd. 0.0380 %	28,190	0.0380 %	63 552 ₩
DFA Australia Ltd. 0.0258 %	19,136	0.0258 %	43 140 ₩
Labgenomics Co. Ltd. Esoa 0.005819 %	4,320	0.005819 %	9 739 ₩

Name	Equities	%	Valuation
ABION INC. 1.12%	245,941	1.12%	1,200,246 $

LabGenomics Co., Ltd.

6/F, Korea Bio Park B 700 Daewangpangyo-ro

13488, Seongnam-si

http://www.labgenomics.co.kr

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
LABGENOMICS CO., LTD.	-28.92%	148M
SONIC HEALTHCARE LIMITED	-16.65%	8.34B
RADNET, INC.	+40.49%	3.59B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-32.64%	2.75B
SYNLAB AG	-8.06%	2.48B
DR. LAL PATHLABS LIMITED	-9.58%	2.32B
NEOGENOMICS, INC.	-14.40%	1.79B
FLEURY S.A.	-18.74%	1.54B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.19%	1.21B
METROPOLIS HEALTHCARE LIMITED	+5.57%	1.13B

Medical & Diagnostic Laboratories